Category

Blastoma

TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control Blastoma

TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control

Proceedings of the National Academy of Sciences, Volume 123, Issue 25, June 2026. SignificanceICAM-1/LFA-1 interactions enhance immune cell avidity, stabilizing immune synapses and improving cytotoxicity in solid tumors. The IFNγ signaling pathway was found to be essential for ICAM1 upregulation. Here, we revealed in glioblastoma that ...Read More
bubmag
June 18, 2026
Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026 Blastoma

Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026

Published : , ,   Dr. Chae-Yong Kim of Seoul National University Bundang Hospital delivers oral presentation on interim data from 10 enrolled patients A manageable safety profile, with prolonged disease control and tumor recurrence inhibition observed in several patients SEONGNAM and SEOUL, South Korea, June 15, 2026 /PRNewswire/ --…
bubmag
June 15, 2026
Hyperbaric Oxygen Therapy’s Dual Role in Glioblastoma | Mirage News Blastoma

Hyperbaric Oxygen Therapy’s Dual Role in Glioblastoma | Mirage News

Glioblastoma remains a highly challenging malignancy with a pronounced tendency for recurrence. The hypoxic microenvironment is a key contributor to its therapy resistance. Hyperbaric oxygen therapy (HBOT), which elevates tissue oxygen pressure and reverses hypoxia, exhibits a "dual effect" in glioblastoma management. On one hand, HBOT enhances radiosensitivity through reactive…
bubmag
April 23, 2026